Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026)
Planet 13 Holdings (PLNH) reported Non-Current Assets of $109.1 million for Q1 2026, down 28.26% year-over-year from $152.1 million in Q1 2025, and down 1.85% quarter-over-quarter from $111.1 million in Q4 2025.
Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Non-Current Assets data on file, last reported at $109.1 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $109.1 million, down 28.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $484.9 million (down 28.38% YoY), and the FY2025 annual result was $111.1 million, down 27.09% from the prior year.
- Non-Current Assets declined to $109.1 million in Q1 2026 per PLNH's latest filing, from $111.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $197.2 million in Q2 2022 and troughed at $104.4 million in Q4 2023.
- A 5-year average of $151.1 million and a median of $152.4 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 51.07% in 2024, then slumped 38.61% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $163.1 million in 2022, then slumped by 35.98% to $104.4 million in 2023, then jumped by 45.96% to $152.4 million in 2024, then fell by 27.09% to $111.1 million in 2025, then slipped by 1.85% to $109.1 million in 2026.
- Business Quant data shows PLNH's Non-Current Assets at $109.1 million in Q1 2026, $111.1 million in Q4 2025, and $113.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | 109.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.08 Mn |
| Dec 31, 2025 | 111.14 Mn |
| Sep 30, 2025 | 113.43 Mn |
| Jun 30, 2025 | 151.21 Mn |
| Mar 31, 2025 | 152.06 Mn |
| Dec 31, 2024 | 152.44 Mn |
| Sep 30, 2024 | 184.78 Mn |
| Jun 30, 2024 | 187.76 Mn |
| Mar 31, 2024 | 104.64 Mn |
| Dec 31, 2023 | 104.44 Mn |
| Sep 30, 2023 | 122.31 Mn |
| Jun 30, 2023 | 163.36 Mn |
| Mar 31, 2023 | 166.01 Mn |
| Dec 31, 2022 | 163.13 Mn |
| Sep 30, 2022 | 194.78 Mn |
| Jun 30, 2022 | 197.15 Mn |
| Mar 31, 2022 | 191.02 Mn |
| Dec 31, 2021 | 135.80 Mn |